Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Rheumatology
•
Anemia
•
Hematology
•
Pediatric Hematology
•
Systemic lupus erythematosus
What is your approach to treatment of warm hemolytic anemia in patients with lupus who have not responded to rituximab and/or cyclophosphamide?
Is there utility for PLEX in these patients?
Related Questions
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
Can lupus anticoagulant be positive despite a normal aPTT?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?